Matches in Wikidata for { <http://www.wikidata.org/entity/Q64223215> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q64223215 description "clinical trial" @default.
- Q64223215 description "ensayu clínicu" @default.
- Q64223215 description "klinisch onderzoek" @default.
- Q64223215 description "клінічне випробування" @default.
- Q64223215 name "A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets" @default.
- Q64223215 type Item @default.
- Q64223215 label "A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets" @default.
- Q64223215 prefLabel "A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets" @default.
- Q64223215 P1050 Q64223215-608F4690-FD7C-494D-B5F7-C1798131A08C @default.
- Q64223215 P1132 Q64223215-07555ACB-60A5-47F6-A1CE-583643D76ABC @default.
- Q64223215 P1476 Q64223215-8558C102-39D5-4BAF-BD74-4DF64DE3D32B @default.
- Q64223215 P17 Q64223215-1E93BBFE-9270-44A6-9687-4CEDFA1DFD36 @default.
- Q64223215 P2899 Q64223215-D02B5365-303D-4285-AF33-F2CB5264519E @default.
- Q64223215 P3098 Q64223215-A4E908FA-2201-45D5-8B02-583FFDB8AB2E @default.
- Q64223215 P31 Q64223215-2A55A19A-04CA-43D3-830F-0C76C917C314 @default.
- Q64223215 P4844 Q64223215-CAD8CFB2-6475-4C00-BB4F-ADC75955CA11 @default.
- Q64223215 P580 Q64223215-F0E48F9E-07E9-4879-A80D-7EED8CC0C111 @default.
- Q64223215 P582 Q64223215-C0D6036D-FABD-4A1F-B837-37489F228CF2 @default.
- Q64223215 P6099 Q64223215-3AD669EF-23BC-47CB-84F0-C68BE91BA83A @default.
- Q64223215 P6099 Q64223215-FA110C32-AFA6-46F6-8F8C-F6F34AD3BEA6 @default.
- Q64223215 P8363 Q64223215-6294A2A0-F492-4C47-B68D-9C6E1D6C10EC @default.
- Q64223215 P1050 Q165328 @default.
- Q64223215 P1132 "+871" @default.
- Q64223215 P1476 "A Phase 2/3, Multicenter, Randomized, Double-blind, Parallel Group Comparative Study to Evaluate the Efficacy and Safety of Once-monthly Oral Administration of NE-58095DR Tablet (25 mg or 37.5 mg) Versus Once-daily Oral Administration of NE-58095IR Tablet (2.5 mg) for the Treatment of Involutional Osteoporosis" @default.
- Q64223215 P17 Q17 @default.
- Q64223215 P2899 "+50" @default.
- Q64223215 P3098 "NCT02063854" @default.
- Q64223215 P31 Q30612 @default.
- Q64223215 P4844 Q408724 @default.
- Q64223215 P580 "2014-02-01T00:00:00Z" @default.
- Q64223215 P582 "2015-11-01T00:00:00Z" @default.
- Q64223215 P6099 Q42824440 @default.
- Q64223215 P6099 Q42824827 @default.
- Q64223215 P8363 Q78089383 @default.